DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS Trademark

Trademark Overview

On Thursday, January 26, 2012, a trademark application was filed for DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS with the United States Patent and Trademark Office. The USPTO has given the DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS trademark a serial number of 85525585. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 22, 2014. This trademark is owned by Bristol-Myers Squibb Company. The DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research and development
declare dapagliflozin evaluation of cardiovascular events

General Information

Serial Number85525585
Word MarkDECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS
Filing DateThursday, January 26, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements

Disclaimer with Predetermined Text"DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 30, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameASTRAZENECA AB
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressSODERTALJE SE-151 85
SE
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Wednesday, October 8, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 19, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 18, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 18, 2013ASSIGNED TO LIE
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 25, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 25, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 25, 2013NON-FINAL ACTION E-MAILED
Thursday, April 25, 2013NON-FINAL ACTION WRITTEN
Wednesday, April 3, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 2, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 2, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 2, 2012FINAL REFUSAL E-MAILED
Tuesday, October 2, 2012FINAL REFUSAL WRITTEN
Monday, September 10, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 10, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 10, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 8, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 8, 2012NON-FINAL ACTION E-MAILED
Thursday, March 8, 2012NON-FINAL ACTION WRITTEN
Thursday, March 1, 2012ASSIGNED TO EXAMINER
Monday, January 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 30, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

events cardiovascular evaluation dapagliflozin declare pharmaceutical research development preparations human relating clinical scientific namely conducting